AdAlta $0.024
(0.00%)
|
High $0.03 |
Low $0.02 |
Trades 24 |
Turnover $54,432 |
Volume 2,170,184 |
| 30 June 2023 at 3:59pm | ||||
ADALTA LIMITED
Pharmaceuticals, Biotechnology & Life Sciences
|
Market Cap (14-Nov) $8,030,422 (1,598th) |
Close (30-Jun) $0.024 |
Volume (30-Jun) 2,170,184 |
Shortsold (2-Feb) 3,141 (0.00%) (662nd) |
|
52w High $0.008 |
52w Low $0.002 |
P/E - |
EPS 0 |
Change in Director Interest Notice x 4
1AD released this announcement to the ASX on 7 July 2021, 11:08. The announcement is not marked as price sensitive, and is 13 page(s) in length and 317.72kb in size.
You can view all announcements from 1AD and see how they appear on a price chart on the announcements page.
| Other Recent Announcements from 1AD | |
|---|---|
| AD-214 clinical trial approval | 29 June 2023, 8:21 |
| Change in substantial holding | 31 May 2023, 13:30 |
| Change in substantial holding | 31 May 2023, 9:34 |
| Change in Director Interest Notice x 4 | 7 July 2021, 11:08 |
| Notification of cessation of securities - 1AD | 2 July 2021, 10:05 |
| Operations Update & Cleansing Notice | 2 July 2021, 9:40 |
| Application for quotation of securities - 1AD | 2 July 2021, 9:33 |
If you were already registered, log in here.
If you were already registered, log in here.